Research Article

Overexpression of Spondin-2 Is Associated with Recurrence-Free Survival in Patients with Localized Clear Cell Renal Cell Carcinoma

Table 3

Uni- and multivariate analyses for predicting recurrence-free survival rate of patients with localized ccRCC.

CharacteristicsUnivariate analysisMultivariate analysis
Hazard ratio (95% confidence interval) valueHazard ratio (95% confidence interval) value

Age (<60 vs. ≥60)3.817 (0.986-14.771)0.052
Gender (female vs. male)1.001 (0.282-3.549)0.998
Tumor diameter (≤4 vs. >4)1.364 (0.392-4.742)0.625
TNM stage (I vs. II)2.832 (1.485-9.523)0.179
Tumor grade (1/2 vs. 3/4)26.651 (7.081-100.313)<0.00114.506 (2.927-71.890)0.001
Necrosis0.468 (0.058-3.752)0.475
Sarcomatoid10.783 (3.117-37.306)<0.00124.145 (4.312-135.215)<0.001
SPON2 protein4.514 (1.736-11.741)0.0020.402 (0.076-2.126)0.284
SPON2 mRNA29.104 (3.672-230.684)0.00161.060 (2.471-1508.739)0.012